FORT WORTH, Texas - Omnicell , Inc. (NASDAQ:OMCL) reported better-than-expected fourth quarter earnings and revenue, but its stock tumbled 4.7% in after-hours trading due to disappointing guidance for ...
The North Carolina not-for-profit healthcare system selected Omnicell's XT automated cabinets as it seeks to enhance patient-care on nursing floors and in perioperative settings. With our ...
In the latest quarter, 4 analysts provided ratings for Omnicell (NASDAQ:OMCL), showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below ...
For the current quarter ending in March, Omnicell expects its per-share earnings to range from 15 cents to 25 cents. The company said it expects revenue in the range of $255 million to $265 million ...
In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Omnicell (OMCL – Research Report). The company’s shares ...
Healthcare tech company Omnicell (NASDAQ:OMCL) will be reporting results tomorrow morning. Here’s what to expect. Omnicell beat analysts’ revenue expectations by 0.6% last quarter, reporting ...
Hosted on MSN3mon
Is Omnicell, Inc. (NASDAQ:OMCL) The Top Stock With Improving Technical Ratings According To Piper Sandler?Omnicell aims to solve this problem. Its products, which consist of automated dispensing systems, medication cabinets and pharmacy robotics, ensure the right medication gets to the right person in ...
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the fourth quarter ...
(NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced results for its fiscal year and ...
Omnicell OMCL is advancing toward the industry-defined vision of Autonomous Pharmacy by leveraging automation and advanced services across its cloud-based platform. The strength of the company’s ...
Get prepared with the key expectations. Enovis, Omnicell and Phreesia have been highlighted in this Industry Outlook article. Zacks Medical Info Systems industry stocks like Enovis, Omnicell and ...
Analyst Allen Lutz of Bank of America Securities maintained a Hold rating on Omnicell (OMCL – Research Report), retaining the price target of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results